Scott Weiner, DO
Orthopaedic Surgery · Farmington, MENPI 1427478130
Payments from drug & device makers
What this record shows
This record is dominated by grants: $10,000 of the $14,574 with a category attached, or 68.6%. Arthrex accounts for 70.9% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $11,682 and has fallen 97.5% since, to $294 in 2025.
Across 28 payments — averaging $520.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$10K
- Gotham Surgical Solutions & Devices, Inc.$1K
- Supreme Orthopedic Systems, LLC$1K
- Stryker$828
- Abbott$161
- Medtronic$157
- plus $427 from 5 others
What the payments were for
- Grants$10,00069%
- Food & beverage$2,08314%
- Education$2,49117%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $10,338 |
| Gotham Surgical Solutions & Devices, Inc. | 3 | $1,370 |
| Supreme Orthopedic Systems, LLC | 2 | $1,293 |
| Stryker | 10 | $828 |
| Abbott | 1 | $161 |
| Medtronic | 2 | $157 |
| Catalyst Orthoscience | 1 | $146 |
| Polaris Technology Solutions LLC | 2 | $94 |
| FX Shoulder Solutions, Inc | 1 | $85 |
| Medartis Inc. | 1 | $78 |
| Bioventus LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REUNION$309
- PROCLAIM$161
- O-ARM-Spine$147
- PANGEA$146
- Catalyst Total CSR$146
- MAKO$104
- TRITANIUM$104
How this compares
$14,574 in reported general payments places this provider in the 80th percentile of 111 orthopaedic surgery providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 11 | $374 |
| Diclofenac Sodium | 14 | $310 |
| Meloxicam | 108 | $289 |
| Methylprednisolone | 45 | $287 |
| Ibuprofen | 13 | $40 |
| Cyclobenzaprine Hcl | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Farmington
- Ian DickeyFarmington$75K
- Andrew CrapserFarmington$43K
- George BabikianFalmouth$446K
- Nicholas ColacchioFalmouth$439K
- Adam RanaFalmouth$330K
- John HerzogFalmouth$258K
- Matthew CamusoPortland$120K
- Daniel ShubertAugusta$64K
- Gregory PomeroyPortland$52K
- Joseph KahanSouth Portland$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.